Safety Alerts & Recalls

What does this mean?

This recall for Nifediac CC (nifedipine), Extended Release Tablets, USP 30 mg, 60 mg and 90 mg was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Nifediac CC (nifedipine), Extended Release Tablets, USP 30 mg, 60 mg and 90 mg and are concerned, you should speak to your doctor or other healthcare professional.

Teva Pharmaceuticals Recalls Several Lots of Nifediac CC (nifedipine), Extended Release Tablets, 30 mg, 60 mg and 90 mg

Teva Pharmaceuticals and Biovail International Corp has recalled several lots of Nifediac CC (nifedipine), Extended Release Tablets, USP 30 mg, 60 mg and 90 mg. The following lot numbers are being recalled because these lots raised a few concerns during the manufacturer routine tests and is being recalled as a precaution: 0901T20A, 0905T11A, 0909T06A, 0912T16A, 0905T12A, 0908T06A, 0907T08A

Nifediac CC contains the active ingredient nifedipine and is commonly used in the treatment of high blood pressure. Nifedipine is also sold under other brand names. This recall alert only applies to the single/select lot of Nifediac CC (nifedipine), Extended Release Tablets, USP 30 mg, 60 mg and 90 mg. No other nifedipine products were involved in this recall.

To view the FDA notice about this recall, please visit: more information here

Source: FDA
Publication Date: 2011-03-05
Last Updated: 2011-03-06

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.